Elevated serum β2M level can also be seen in patients with solid cancers, such as ovarian cancer (293), gall bladder cancer (294), prostate cancer (295), breast cancer (296), and renal cell carcinoma (297). This evidence concerns the gene B2M and ovarian carcinoma.